The impact of acetylcholinesterase inhibitors on the extracellular acetylcholine concentrations in the adult rat brain: A meta-analysis

Synapse

Volumn 66, Issue 10, 2012, Pages 893-901

  Noori, Hamid R ^a   Fliegel, Sarah ^a   Brand, Ines ^a   Spanagel, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetylcholine; Acetylcholinesterase inhibitors; Caudate putamen; Hippocampus; Meta analysis; Microdialysis; Nucleus accumbens; Prefrontal cortex; Rat

Indexed keywords

ACETYLCHOLINE; AUTORECEPTOR; CHOLINESTERASE INHIBITOR; NEOSTIGMINE; PHYSOSTIGMINE;

ARTICLE; CAUDATE NUCLEUS; CAUDATE PUTAMEN; HIPPOCAMPUS; IN VIVO STUDY; META ANALYSIS; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRESYNAPTIC NERVE; PRIORITY JOURNAL;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; BRAIN CHEMISTRY; CHOLINESTERASE INHIBITORS; GPI-LINKED PROTEINS; INHIBITORY CONCENTRATION 50; NEOSTIGMINE; PHYSOSTIGMINE; RATS;

EID: 84864628610     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21581     Document Type: Article

References (107)

1. Acquas E, Di Chiara G. 1999a. Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. Eur J Pharmacol 383: 121-127.
2. Acquas E, Di Chiara G. 1999b. Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur J Pharmacol 383: 275-279.
3. Acquas E, Pisanu A, Marrocu P, Di Chiara G. 2000. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol 401: 179-185.
4. Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, Di Chiara G. 2001a. Intravenous administration of ecstasy (3, 4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur J Pharmacol 418: 207-211.
5. Acquas E, Pisanu A, Marrocu P, Goldberg SR, Di Chiara G. 2001b. Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study. Eur J Pharmacol 419: 155-161.
6. Ago Y, Sato M, Nakamura S, Baba A, Matsuda T. 2006. Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex. J Pharmacol Sci 102: 419-422.
7. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. 2009. Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 89: 73-120.
8. Antoniou K, Kehr J, Snitt K, Ogren SO. 1997. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats. Br J Pharmacol 121: 1180-1186.
9. Anzalone S, Vetreno RP, Ramos RL, Savage LM. 2010. Cortical cholinergic abnormalities contribute to the amnesic state induced by pyrithiamine-induced thiamine deficiency in the rat. Eur J Neurosci 32: 847-858.
10. Bardo MT, Rowlett JK, Harris MJ. 1995. Conditioned place preference using opiate and stimulant drugs: A meta-analysis. Neurosci Biobehav Rev 19: 39-51.
11. Benignus VA, Bushnell PJ, Boyes WK, Eklund C, Kenyon EM. 2009. Neurobehavioral effects of acute exposure to four solvents: Meta-analyses. Toxicol Sci 109: 296-305.
12. Bito-Onon JJ, Simms JA, Chatterjee S, Holgate J, Bartlett SE. 2011. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. Addict Biol 16: 440-449.
13. Biton B, Bergis OE, Galli F, Nedelec A, Lochead AW, Jegham S, Godet D, Lanneau C, Santamaria R, Chesney F, Leonardon J, Granger P, Debono MW, Bohme GA, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Vige X, Voltz C, Rouquier L, Souilhac J, Santucci V, Gueudet C, Francon D, Steinberg R, Griebel G, Oury-Donat F, George P, Avenet P, Scatton B. 2007. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile. Neuropsychopharmacology 32: 1-16.
14. Buchholzer ML, Dvorak C, Chatterjee SS, Klein J. 2002. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort. J Pharmacol Exp Ther 301: 714-719.
15. Castañeda TR, de Prado BM, Prieto D, Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 36: 177-185.
16. Claustre Y, Rouquier L, Desvignes C, Leonetti M, Montegut J, Aubin N, Allouard N, Bougault I, Oury-Donat F, Steinberg R. 2006. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat. Neuroscience 141: 1481-1488.
17. Consolo S, Caltavuturo C, Colli E, Recchia M, Di Chiara G. 1999. Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Neuroscience 89: 1209-1217.
18. Crespo JA, Sturm K, Saria A, Zernig G. 2006. Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 26: 6004-6010.
19. Crespo JA, Stöckl P, Zorn K, Saria A, Zernig G. 2008. Nucleus accumbens core acetylcholine is preferentially activated during acquisition of drug- vs food-reinforced behavior. Neuropsychopharmacology 33: 3213-3220.
20. Damsma G, Westerink BHC, DeVries JB, DeBoer P, Horn AS. 1988. Determination of basal acetylcholine release in freely moving rats by transstriatal dialysis coupled to HPLC analysis: Pharmacological aspects. Life Sci 43: 1161-1168.
21. Day J, Damsma G, Fibiger HC. 1991. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study. Pharmacol Biochem Behav 38: 723-729.
22. DeBoer P, Damsma G, Fibiger HC, Timmerman W, de Vries JB, Westerink BHC. 1990a. Dopaminergic-cholinergic interactions in the striatum: The critical significance of calcium concentrations in brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 342: 528-534.
23. DeBoer P, Westerink BHC, Horn AS. 1990b. The effects of acetylcholinesterase inhibition on the release of acetylcholine from the striatum in vivo: Interaction with autoreceptor responses. Neurosci Lett 116: 357-360.
24. Del Arco A, Mora F, Mohammed AH, Fuxe K. 2007. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens. J Neural Transm 114: 185-193.
25. Del Arco A, Segovia G, Mora F. 2008. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity. Psychopharmacology (Berl) 201: 325-338.
26. De Parada MP, Parada MA, Rada P, Hernandez L, Hoebel BG. 2000. Dopamine-acetylcholine interaction in the rat lateral hypothalamus in the control of locomotion. Pharmacol Biochem Behav 66: 227-234.
27. Deiana S, Platt B, Riedel G. 2011. The cholinergic system and spatial learning. Behav Brain Res 221: 389-411.
28. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK. 1985. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N Engl J Med 313: 7-11.
29. Frank ST, Krumm B, Spanagel R. 2008. Cocaine-induced dopamine overflow within the nucleus accumbens measured by in vivo microdialysis: a meta-analysis. Synapse 62: 243-252.
30. Giovannini MG, Mutolo D, Bianchi L, Michelassi A, Pepeu G. 1994. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study. J Neurosci 14: 1358-1365.
31. Giovannini MG, Camilli F, Mundula A, Pepeu G. 1994a. Glutamatergic regulation of acetylcholine output in different brain regions: A microdialysis study in the rat. Neurochem Int 25: 23-26.
32. Giovannini MG, Camilli F, Mundula A, Bianchi L, Colivicchi MA, Pepeu G. 1995. Differential regulation by N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors of acetylcholine release from the rat striatum in vivo. Neuroscience 65: 409-415.
33. Giovannini MG, Pazzagli M, Malmberg-Aiello P, Della Corte L, Rakovska AD, Cerbai F, Casamenti F, Pepeu G. 2005. Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat. Neuroscience 136: 15-32.
34. Glass GV. 1976. Primary, secondary and meta-analysis of research. Educ Res 5: 3-8.
35. Gold PE, Countryman RA, Dukala D, Chang Q. 2011. Acetylcholine release in the hippocampus and prelimbic cortex during acquisition of a socially transmitted food preference. Neurobiol Learn Mem 96: 498-503.
36. Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, Brunk I, Spanagel R, Ahnert-Hilger G, Meijer JH, Albrecht U. 2008. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 18: 678-683.
37. Harada H, Hosonuma K, Fujii T, Kawashima K. 2000. Enhancement of cerebral cortical acetylcholine release by intraperitoneal acetic acid and its suppression by analgesics in freely moving rats. Neurosci Lett 284: 163-166.
38. Hasegawa M, Yamada K, Hasegawa T, Nabeshima T. 1996. Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain. J Neural Transm 103: 651-660.
39. Hedges LV, Olkin I. 1985. Statistical methods for meta-analysis, Chapter 8. Orlando, FL: Academic Press. p 169-170.
40. Herman AI, Sofuoglu M. 2010. Cognitive effects of nicotine: Genetic moderators. Addict Biol 15: 250-265.
41. Hernandez LF, Segovia G, Mora F. 2003. Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: A microdialysis study. Neurochem Res 28: 1819-1827.
42. Hernandez LF, Segovia G, Mora F. 2006. Changes in dopamine and acetylcholine in striatum of the awake rat after chronic treatment with a dopamine uptake blocker. Brain Res Bull 68: 448-452.
43. Hernandez LF, Segovia G, Mora F. 2008. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat. Neurochem Int 52: 457-469.
44. Horii A, Takeda N, Mochizuki T, Okakura-Mochizuki K, Yamamoto Y, Yamatodani A. 1994. Effects of vestibular stimulation on acetylcholine release from rat hippocampus: An in vivo microdialysis study. J Neurophysiol 72: 605-611.
45. Huang M, Li Z, Dai J, Shahid M, Wong EH, Meltzer HY. 2008. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Neuropsychopharmacology 33: 2934-2945.
46. Hut RA and Van der Zee EA. 2011. The cholinergic system, circadian rhythmicity, and time memory. Behav Brain Res 221: 466-480.
47. Ichikawa J, Dai J, Meltzer HY. 2002a. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex. Brain Res 939: 34-42.
48. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. 2002b. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26: 325-339.
49. Ichikawa J, Li Z, Dai J, Meltzer HY. 2002c. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: Role of 5-HT1A receptor agonism. Brain Res 956: 349-357.
50. Ikarashi Y, Yuzurihara M. 2002. Potentiation by saiboku-to of diazepam-induced decreases in hippocampal and striatal acetylcholine release in rats. Phytomedicine 9: 700-708.
51. Inagawa G, Sato K, Kikuchi T, Nishihama M, Shioda M, Koyama Y, Yamada Y, Andoh T. 2004. Opposite effects of depressant and convulsant barbiturate stereoisomers on acetylcholine release from the rat hippocampus in vivo. Br J Anaesth 92: 424-426.
52. Inagawa G, Sato K, Kikuchi T, Nishihama M, Shioda M, Koyama Y, Yamada Y, Andoh T. 2004a. Chronic ethanol consumption does not affect action of propofol on rat hippocampal acetylcholine release in vivo. Br J Anaesth 93: 737-739.
53. Ishida K, Murata M, Kato M, Utsunomiya I, Hoshi K, Taguchi K. 2005. Beta-phenylethylamine stimulates striatal acetylcholine release through activation of the AMPA glutamatergic pathway. Biol Pharm Bull 28: 1626-1629.
54. Izaki Y, Hori K, Nomura M. 2001. Elevation of prefrontal acetylcholine is related to the extinction of learned behavior in rats. Neurosci Lett 306: 33-36.
55. Jamal M, Ameno K, Wang W, Kumihashi M, Ameno S, Ikuo U, Shinji A, Ijiri I. 2005. Inhibition of acetaldehyde metabolism decreases acetylcholine release in medial frontal cortex of freely moving rats. Brain Res 1039: 90-96.
56. Jansson A, Olin K, Yoshitake T, Hagman B, Herrington MK, Kehr J, Permert J. 2004. Effects of isoflurane on prefrontal acetylcholine release and hypothalamic Fos response in young adult and aged rats. Exp Neurol 190: 535-554.
57. Jonasson Z. 2005. Meta-analysis of sex differences in rodent models of learning and memory: A review of behavioural and biological data. Neurosci Biobehav Rev 28: 811-825.
58. Kato M, Ishida K, Chuma T, Abe K, Shigenaga T, Taguchi K, Miyatake T. 2001. Beta-phenylethylamine modulates acetylcholine release in the rat striatum: involvement of a dopamine D(2) receptor mechanism. Eur J Pharmacol 418: 65-71.
59. Keita MS, Frankel-Kohn L, Bertrand N, Lecanu L, Monmaur P. 2000. Acetylcholine release in the hippocampus of the urethane anaesthetised rat positively correlates with both peak theta frequency and relative power in the theta band. Brain Res 887: 323-334.
60. Keys AS, Mark GP. 1998. D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens. Neuroscience 86: 521-531.
61. Kiewert C, Buchholzer ML, Hartmann J, Chatterjee SS, Klein J. 2004. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort. Neurosci Lett 364: 195-198.
62. Kikuchi T, Wang Y, Sato K, Okumura F. 1998. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats. Br J Anaesth 80: 644-648.
63. Lacroix LP, Ceolin L, Zocchi A, Varnier G, Garzotti M, Curcuruto O, Heidbreder CA. 2006. Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anti-cholinesterases. J Neurosci Methods 157: 25-31.
64. Laplante F, Morin Y, Quirion R, Vaucher E. 2005. Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: A dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience 132: 501-510.
65. Lester DB, Rogers TD, Blaha CD. 2010. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 16: 137-162.
66. Li Z, Bonhaus DW, Huang M, Prus AJ, Dai J, Meltzer HY. 2007. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1, 4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus. Eur J Pharmacol 572: 129-137.
67. Li Z, Snigdha S, Roseman AS, Dai J, Meltzer HY. 2008. Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1, 4]oxazin-3-one (AC260584) and N-desmethylclozapine. Eur J Pharmacol 596: 89-97.
68. Lindefors N, Hurd YL, O'Connor WT, Brene S, Persson H, Ungerstedt U. 1992. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience 48: 439-448.
69. Liu JK, Takeshi K. 1994. Effects of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex. Neurochem Int 24: 589-596.
70. Mark GP, Rada PV, Shors TJ. 1996. Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala. Neuroscience 74: 767-774.
71. Messamore E, Warpman U, Williams E, Giacobini E. 1993. Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition. Neurosci Lett 158: 205-208.
72. Moor E, de Boer P, Beldhuis HJ, Westerink BH. 1994. A novel approach for studying septo-hippocampal cholinergic neurons in freely moving rats: A microdialysis study with dual-probe design. Brain Res 648: 32-38.
73. Moor E, DeBoer P, Auth F, Westerink BH. 1995. Characterisation of muscarinic autoreceptors in the septo-hippocampal system of the rat: A microdialysis study. Eur J Pharmacol 294: 155-161.
74. Moor E, Schirm E, Jacsó J, Westerink BH. 1998. Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus. Neuroscience 82: 819-825.
75. Mork A, Witten LM, Arnt J. 2009. Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: A comparison with risperidone and exploration of mechanisms involved. Psychopharmacology (Berl) 206: 39-49.
76. Nair SG, Gudelsky GA. 2004. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat. Synapse 53: 202-207.
77. Nair SG, Gudelsky GA. 2006a. Effect of a serotonin depleting regimen of 3, 4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Res Bull 69: 382-387.
78. Nair SG, Gudelsky GA. 2006b. 3, 4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. Psychopharmacology (Berl) 184: 182-189.
79. Parada MA, Hernandez L, Puig de Parada M, Rada P, Murzi E. 1997. Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum. J Pharmacol Exp Ther 281: 582-588.
80. Parades D, Rada P, Bonilla E, Gonzalez LE, Parada M, Hernandez L. 1999. Melatonin acts on the nucleus accumbens to increase acetylcholine release and modify the motor activity pattern of rats. Brain Res 850: 14-20.
81. Passetti F, Dalley JW, O'Connell MT, Everitt BJ, Robbins TW. 2000. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci 12: 3051-3058.
82. Paxinos G, Watson C. 2008. The rat brain in stereotaxic coordinates. New York: Academic Press.
83. Petkova-Kirova P, Rakovska A, Della Corte L, Zaekova G, Radomirov R, Mayer A. 2008. Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis. Brain Res Bull 77: 129-135.
84. Phillis JW. 2005. Acetylcholine release from the central nervous system: A 50-year retrospective. Crit Rev Neurobiol 17: 161-217.
85. Pisanu A, Acquas E, Fenu S, Di Chiara G. 2006. Modulation of delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors. Neuropharmacology 50: 661-670.
86. Pych JC, Chang Q, Colon-Rivera C, Gold PE. 2005. Acetylcholine release in hippocampus and striatum during testing on a rewarded spontaneous alternation task. Neurobiol Learn Mem 84: 93-101.
87. Quarta D, Ciruela F, Patkar K, Borycz J, Solinas M, Lluis C, Franco R, Wise RA, Goldberg SR, Hope BT, Woods AS, Ferré S. 2007. Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. Neuropsychopharmacology 32: 35-42.
88. Rada P, Johnson DF, Lewis MJ, Hoebel BG. 2004. In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: Evidence of opioid withdrawal. Pharmacol Biochem Behav 79: 599-605.
89. Rada P, Colasante C, Skirzewski M, Hernandez L, Hoebel B. 2006. Behavioral depression in the swim test causes a biphasic, long-lasting change in accumbens acetylcholine release, with partial compensation by acetylcholinesterase and muscarinic-1 receptors. Neuroscience 141: 67-76.
90. Rada P, Barson JR, Leibowitz SF, Hoebel BG. 2010. Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens. Brain Res 1312: 1-9.
91. Rakovska A, Giovannini MG, Della Corte L, Kalfin R, Bianchi L, Pepeu G. 1998. Neurotensin modulation of acetylcholine and GABA release from the rat hippocampus: An in vivo microdialysis study. Neurochem Int 33: 335-340.
92. Rakovska A, Kiss JP, Raichev P, Lazarova M, Kalfin R, Djambazova E. 2002. The non-competitive AMPA receptor antagonist (GYKI 52466) blocks quisqualate-induced acetylcholine release from the rat hippocampus and striatum: an in vivo microdialysis study. Neurochem Int 40: 419-426.
93. Reid RT, Lloyd GK, Rao TS. 1999. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: Evidence for a permissive dopamine synapse. Br J Pharmacol 127: 1486-1494.
94. Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T. 2007. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex. Eur J Pharmacol 559: 155-160.
95. Smith ML, Glass GV. 1977. Meta-analysis of psychotherapy outcome studies. Am Psychol 32: 752-760.
96. Steinberg R, Marco N, Voutsinos B, Bensaid M, Rodier D, Souilhac J, Alonso R, Oury-Donat F, Le Fur G, Soubrie P. 1998. Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. Eur J Neurosci 10: 2337-2345.
97. Taguchi K, Atobe J, Kato M, Chuma T, Chikuma T, Shigenaga T, Miyatake T. 1998. The effect of methamphetamine on the release of acetylcholine in the rat striatum. Eur J Pharmacol 360: 131-137.
98. Tani Y, Saito K, Imoto M, Ohno T. 1998. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--An in vivo microdialysis study. Eur J Pharmacol 351: 181-188.
99. Tellez S, Colpaert F, Marien M. 1999. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience 89: 1041-1050.
100. Triggle DJ, Mitchell JM, Filler R. 1998. The pharmacology of physostigmine. CNS Drug Rev 4: 87-136.
101. Verrico CD, Jentsch JD, Dazzi L, Roth RH. 2003. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. Synapse 48: 178-183.
102. Vetulani J, Roman A, Kowalska M, Nalepa I. 2010. Paroxetine pretreatment does not change the effects induced in the rat cortical beta-adrenergic receptor system by repetitive transcranial magnetic stimulation and electroconvulsive shock. Int J Neuropsychopharmacol 13: 737-746.
103. Wang Y, Kikuchi T, Sakai M, Wu JL, Sato K, Okumura F. 2000. Age-related modifications of effects of ketamine and propofol on rat hippocampal acetylcholine release studied by in vivo brain microdialysis. Acta Anaesthesiol Scand 44: 112-117.
104. Weinstock M. 1995. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: An update. Neurodegeneration 4: 349-356.
105. Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, Gradinaru V, Ramakrishnan C, Deisseroth K. 2010. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 330: 1677-1681.
106. Zangen A, Hyodo K. 2002. Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport 13: 2401-2405.
107. Zhelyazkova-Savova M, Giovannini MG, Pepeu G. 1999. Systemic chlorophenylpiperazine increases acetylcholine release from rat hippocampus-implication of 5-HT2C receptors. Pharmacol Res 40: 165-170.